602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPY

✍ Scribed by P. Colombatto; M.R. Brunetto; A.M. Maina; V. Romagnoli; A. Craxì; P. Almasio; S. Madonia; M.G. Rumi; M. Colombo; S. Fargion; A. Ascione; G. Pinzello; M. Mondelli; A. Muzzi; F. Bianchi; V. Barnaba; M. Sarracino; R. Rappuoli; D. Rosa; S. Montigiani; S. Abrignani; M. Houghton; F. Bonino

• Book ID: 117377611
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 53 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(09)60604-8